Letters Glucagon-like peptide-1 drugs

Are GLP-1 analogues affordable?

BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d1482 (Published 08 March 2011) Cite this as: BMJ 2011;342:d1482
  1. Donald Macaulay, general practitioner1
  1. 1Blackburn Health Centre, Bathgate, West Lothian EH47 7LL, UK
  1. drdmacaulay{at}hotmail.com

Glucagon-like peptide-1 analogues (GLP-1) seem to have been rapidly taken up by diabetologists. Yet without long term trials, nothing seems to have been learnt from the rush into rosiglitazone. As Wilding and Hardy state, “Neither exenatide nor liraglutide has been formally studied with, or has a licence for use in combination with, insulin; however, exenatide is sometimes used with …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe